Alto Neuroscience (ANRO) Other financing activities (2023 - 2025)

Alto Neuroscience (ANRO) has 3 years of Other financing activities data on file, last reported at $703000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other financing activities changed N/A year-over-year to $703000.0; the trailing twelve-month figure through Mar 2026 stood at $505000.0 (up 155.05% YoY), and the FY2025 full-year result was $703000.0, down 99.49% from the prior year.
• Other financing activities improved to $703000.0 in Q4 2025, from -$524000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $137.6 million in Q1 2024 to a low of -$137.6 million in Q2 2024.
• A 3-year average of $15.4 million and a median of $198000.0 in 2025 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 320051.16% in 2024, while the deepest fall reached 320051.16% in 2024.
• Tracing ANRO's Other financing activities over 3 years: stood at -$43000.0 in 2023, then jumped by 320051.16% to $137.6 million in 2024, then tumbled by 99.49% to $703000.0 in 2025.
• Business Quant data shows ANRO's Other financing activities at $703000.0 in Q4 2025, -$524000.0 in Q3 2025, and $326000.0 in Q2 2025.